Target intelligence / Profile preview

Molybdate-anion transporter (SLC61A1)

Target
SLC61A1
Molecular classification
Transporter, Major facilitator superfamily (MFS), Solute carrier family
01

Overview

Molybdate-anion transporter (SLC61A1, also known as MFSD5) is a multi-pass membrane protein that functions as a high-affinity transporter for molybdate ions, a biologically essential trace element involved in the function of various enzymes. It belongs to the major facilitator superfamily (MFS) of transporters and is predicted to mediate the uptake of molybdate across cellular membranes, particularly in neuronal plasma membranes[1][4][6][8]. While it is a plausible therapeutic target due to its transporter function, there are no established interacting drugs or clear roles in major human diseases. The gene is located in the plasma membrane and is considered an atypical member of the solute carrier transporter family, specifically designated SLC61A1[1][2][6][8]. The precise physiological and pathological roles remain under investigation, but associated studies suggest a potential link to extratemporal epilepsy[8]. No current therapy targets this transporter, and no safety or biomarker issues are defined.

Other names
MFSD5hsMOT2Major facilitator superfamily domain-containing protein 5SLC61A1MGC11308Molybdate transporter 2 homologmolybdate-anion transporter
02

Mechanism of action

Not established for drug action; mediates high-affinity intracellular uptake of molybdate ions

03

Biological functions

Molybdate ion transmembrane transportMolybdate ion homeostasisTransport of inorganic anions across membranes
04

Disease associations

Other (potential relevance in diseases such as extratemporal epilepsy)

Beyond the preview

Go deeper on Molybdate-anion transporter (SLC61A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molybdate-anion transporter (SLC61A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call